AI & Technology
Novartis’s Christian Diehl on scaling AI beyond the demo
- Source:
- McKinsey & Company
- Published:
- 21 September 2026
In this McKinsey & Company excerpt, Novartis’s chief data and digital officer for biomedical research explains how investments in data platforms are paying off. The benefits span AI safety prediction, generative chemistry, and faster translation.
Summary by TAWAJOH TECH. Read the original for the full text.
Read original source (opens in a new tab)
TAWAJOH TECH